{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:23:16Z","timestamp":1790144596700,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"World Health Organization-Eastern Mediterranean Regional Office\/Tropical Disease Research Programme","award":["43119022"],"award-info":[{"award-number":["43119022"]}]},{"name":"World Health Organization-Eastern Mediterranean Regional Office\/Tropical Disease Research Programme","award":["43119040"],"award-info":[{"award-number":["43119040"]}]},{"name":"Tehran University of Medical Sciences\u2019 Office of the Deputy of Research","award":["3895-55-02-85"],"award-info":[{"award-number":["3895-55-02-85"]}]},{"DOI":"10.13039\/100011944","name":"John P. Dowdle Endowment and the Russell M. Grossman Medical Research Fund of the School of Public Health, University of California, Berkeley","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"crossref"}]},{"name":"US National Institute for Drug Abuse (NIDA)","award":["1R21DA029473-01"],"award-info":[{"award-number":["1R21DA029473-01"]}]}],"content-domain":{"domain":["ijdp.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.drugpo.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T16:24:49Z","timestamp":1401726289000},"page":"717-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Access to harm reduction programs among persons who inject drugs: Findings from a respondent-driven sampling survey in Tehran, Iran"],"prefix":"10.1016","volume":"25","author":[{"given":"Ruyan","family":"Rahnama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Mohraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0707-8287","authenticated-orcid":false,"given":"George","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Malekinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.drugpo.2014.05.013_bib0005","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1089\/jwh.2010.2694","article-title":"Characteristics of Iranian women seeking drug treatment","volume":"20","author":"Dolan","year":"2011","journal-title":"Journal of Women's Health (Larchmt)"},{"issue":"9534","key":"10.1016\/j.drugpo.2014.05.013_bib0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(06)69132-0","article-title":"HIV\/AIDS harm reduction in Iran","volume":"368","author":"Emran","year":"2006","journal-title":"The Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2014.05.013_bib0015","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.aids.0000386733.02425.98","article-title":"HIV\/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: Results of the first biobehavioral surveys","volume":"24","author":"Mahfoud","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0020","unstructured":"Malekinejad, M. (2008). Assessment of the use of respondent-driven sampling for studying populations most at risk of HIV infection (Doctoral dissertation). Dr. P.H, University of California."},{"issue":"4","key":"10.1016\/j.drugpo.2014.05.013_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.drugpo.2011.09.001","article-title":"Transition to injection amongst opioid users in Iran: Implications for harm reduction","volume":"23","author":"Malekinejad","year":"2012","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0030","series-title":"Monitoring the AIDS Pandemic (MAP) Provisional Report","article-title":"The Status and Trends of HIV\/AIDS\/STI Epidemics in Asia and the Pacific","author":"MAP Network","year":"2001"},{"issue":"1","key":"10.1016\/j.drugpo.2014.05.013_bib0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/EDE.0b013e31823ac17c","article-title":"Evaluation of respondent-driven sampling","volume":"23","author":"McCreesh","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0040","series-title":"Islamic Republic of Iran Progress Report: On Monitoring of the United Nations Special Session on HIV and AIDS","author":"Ministry of Health and Medical Education","year":"2012"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0045","series-title":"Drug abuse and HIV transmission in Iran \u2013 Responding to public health challenges. Public health aspects of HIV\/AIDS in low and middle income countries: Epidemiology, prevention and care","first-page":"583","author":"Mokri","year":"2008"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0050","series-title":"Briefing Paper 8: The Beckley Foundation Drug Policy Programme","article-title":"The risk of harm reduction in the Islamic Republic of Iran","author":"Nissaramanesh","year":"2005"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0055","series-title":"Geographical distribution of mental, social, and addiction in 2007: Substance use version","author":"Noroozi","year":"2007"},{"issue":"10","key":"10.1016\/j.drugpo.2014.05.013_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7517-10-13","article-title":"Availability of HIV prevention and treatment services for people who inject drugs: Findings from 21 countries","volume":"19","author":"Petersen","year":"2013","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.drugpo.2014.05.013_bib0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugpo.2011.09.002","article-title":"HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998\u20132007","volume":"23","author":"Rahimi-Movaghar","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"9","key":"10.1016\/j.drugpo.2014.05.013_bib0070","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1360-0443.2007.01914.x","article-title":"HIV risk behavior among injection drug users in Tehran, Iran","volume":"102","author":"Razani","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0075","series-title":"Rapid assessment of drug misuse in Iran, Tehran 1998\u20131999","author":"Razzaghi","year":"2000"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7517-3-12","article-title":"Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran","volume":"3","author":"Razzaghi","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.drugpo.2014.05.013_bib0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/002204260103100401","article-title":"Current methods of assessing substance use: A review of strengths, problems, and developments","volume":"31","author":"Richter","year":"2001","journal-title":"Journal of Drug Issues"},{"issue":"6","key":"10.1016\/j.drugpo.2014.05.013_bib0090","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s10461-013-0451-y","article-title":"The importance of measuring and accounting for potential biases in respondent-driven samples","volume":"17","author":"Rudolph","year":"2013","journal-title":"AIDS and Behavior"},{"issue":"Suppl. 3","key":"10.1016\/j.drugpo.2014.05.013_bib0095","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/QAI.0b013e3181aafd3f","article-title":"HIV surveillance and epidemic profile in the Middle East and North Africa","volume":"51","author":"Shawky","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0100","article-title":"Iran faces up to its most lethal threat-drugs","author":"Tait","year":"2005","journal-title":"The Guardian"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-7517-2-19","article-title":"Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study","volume":"2","author":"Vazirian","year":"2005","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2014.05.013_bib0110","series-title":"Best practice in HIV\/AIDS prevention and care for injecting drug abusers: The triangular clinic in Kermanshah, Islamic Republic of Iran","author":"WHO Regional Office for the Eastern Mediterranean","year":"2004"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914001443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914001443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:11:18Z","timestamp":1589227878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395914001443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0955395914001443"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.05.013","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to harm reduction programs among persons who inject drugs: Findings from a respondent-driven sampling survey in Tehran, Iran","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}